Clinical Tests Begin On Medication To Correct Fragile X Defect
Wednesday, November 4, 2009 - 01:28
in Health & Medicine
Scientists are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability and optimal dosage in healthy volunteers.
Read the whole article on Science Daily
More from Science Daily
Related
- Clinical tests begin on medication to correct Fragile X defectMon, 2 Nov 2009, 12:44:07 EST
- UCR researchers propose minocycline as a promising drug for patients with Fragile X syndromeFri, 3 Oct 2008, 11:42:43 EDT
- Promising new drug being evaluated as possible treatment option for fragile X syndromeWed, 7 Jan 2009, 9:51:28 EST
- Melatonin is an effective treatment for sleep problems in children with autismWed, 15 Apr 2009, 0:42:58 EDT
- Lack of fragile X and related gene fractures sleepThu, 26 Jun 2008, 12:36:06 EDT